Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
Titel:
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
Auteur:
Pal, Sumanta Kumar Uzzo, Robert Karam, Jose Antonio Master, Viraj A Donskov, Frede Suarez, Cristina Albiges, Laurence Rini, Brian Tomita, Yoshihiko Kann, Ariel Galapo Procopio, Giuseppe Massari, Francesco Zibelman, Matthew Antonyan, Igor Huseni, Mahrukh Basu, Debasmita Ci, Bo Leung, William Khan, Omara Dubey, Sarita Bex, Axel